Lessons learned from two randomized controlled trials: CITIES and STOP-DKD
Leah L Zullig, Megan M Oakes, Felicia McCant, Hayden B Bosworth, Leah L Zullig, Megan M Oakes, Felicia McCant, Hayden B Bosworth
Abstract
Background: Even well-designed, theoretically driven clinical trials can fall short of achieving the desired clinical outcomes. Our research team had an opportunity to conduct two randomized controlled trials that were enrolling patients in parallel. While both studies were targeting chronic disease management among patients with multiple comorbid conditions, the patient population and settings varied. The studies were the Cardiovascular Intervention Improvement Telemedicine Study (CITIES) and Simultaneous Risk Factor Control Using Telehealth to slow Progression of Diabetic Kidney Disease (STOP-DKD) studies. Both studies had null findings.
Objectives: Our goal is to discuss common design considerations across CITIES and STOP-DKD and potential implications for the design of future randomized controlled trials.
Methods: These were two 1:1 randomized controlled trials with attention control groups that recruited patients from various clinical practices in the Research Triangle area of North Carolina.
Conclusions: We make three recommendations for future studies. First, we assert that it is important to allow for piloting the enrollment process to ensure that it is possible to identify and recruit a patient population that is well aligned with the clinical outcomes of the intervention. Second, analysis plans should be more targeted in their approach and should consider heterogeneity of treatment effects. Third, in order to support the transition of evidence generated from randomized controlled trials into clinical practice, it is important to consider even early stage randomized controlled trials through an implementation science lens.
Trial registration: Simultaneous Risk Factor Control Using Telehealth to slow Progression of Diabetic Kidney Disease (STOP-DKD) NCT01829256; Cardiovascular Intervention Improvement Telemedicine Study NCT01142908.
Keywords: Cardiovascular disease; Clinical trials as a topic; Medication adherence; Pharmacists; Research design.
© 2020 Published by Elsevier Inc.
References
- Chalmers I., Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet (N. Am. Ed.) 2009;374(9683):86–89.
- Glasziou P., Altman D.G., Bossuyt P. Reducing waste from incomplete or unusable reports of biomedical research. Lancet (N. Am. Ed.) 2014;383(9913):267–276.
- Franco A., Malhotra N., Simonovits G. Social science. Publication bias in the social sciences: unlocking the file drawer. Science. 2014;345(6203):1502–1505.
- Dickersin K., Chan S., Chalmers T.C., Sacks H.S., Smith H., Jr. Publication bias and clinical trials. Contr. Clin. Trials. 1987;8(4):343–353.
- Murray S.B., Heathers J.A., Schauer R.M. Postpublication metrics of randomized clinical trials with and without null findings. Jama. 2019;321(18):1825–1826.
- Bosworth H.B., Olsen M.K., McCant F. Telemedicine cardiovascular risk reduction in veterans: the CITIES trial. Am. Heart J. 2018;199:122–129.
- Goldstein K.M., Melnyk S.D., Zullig L.L. Heart matters: gender and racial differences cardiovascular disease risk factor control among veterans. Wom. Health Issues : Off. Pub. Jacobs Inst. Womens's Health. 2014;24(5):477–483.
- Melnyk S.D., Zullig L.L., McCant F. Telemedicine cardiovascular risk reduction in veterans. Am. Heart J. 2013;165(4):501–508.
- Zullig L.L., Melnyk S.D., Stechuchak K.M. The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction. Telemed. J. e Health : Off. J. Am. Telemed. Assoc. 2014;20(2):135–143.
- Diamantidis C.J., Bosworth H.B., Oakes M.M. Simultaneous risk factor control using Telehealth to slOw progression of diabetic kidney disease (STOP-DKD) study: protocol and baseline characteristics of a randomized controlled trial. Contemp. Clin. Trials. 2018;69:28–39.
- Zullig L.L., Diamantidis C.J., Bosworth H.B. Racial differences in nocturnal dipping status in diabetic kidney disease: results from the STOP-DKD (simultaneous risk factor control using Telehealth to slow progression of diabetic kidney disease) study. J. Clin. Hypertens. 2017;19(12):1327–1335.
- Zullig L.L., Jazowski S.A., Davenport C.A. Primary care providers’ acceptance of pharmacists’ recommendations to support optimal medication management for patients with diabetic kidney disease. J. Gen. Intern. Med. 2019;35(1):63–69. doi: 10.1007/s11606-019-05403-x. Epub 2019 Oct 28.
- D'Agostino Rb Sr, Vasan R.S., Pencina M.J. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753.
- James P.A., Oparil S., Carter B.L. vol. 311. 2014. Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) pp. 507–520. 2014. 5.
Source: PubMed